IMNM
Immunome Inc
25.80$
+2.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
Immunome Inc (IMNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.6 | -17 | -11 | -23 | -34 | -42 | -53 | -49 | -41 | -48 | -59 | -62 | -209 | |
| 0.2 | 0.3 | 0.3 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 1.2 | 3.4 | |
| 1.1 | 2.9 | 2.2 | 3.2 | 4.9 | 5.5 | 5.7 | 5.3 | 6.7 | 7.9 | 8.0 | 8.8 | 31 | |
| -5.9 | -7.9 | 4.5 | 2.9 | 2.2 | 5.3 | -17 | -12 | 10 | 3.2 | -14 | 1.9 | 1.9 | |
| 0.0 | 0.3 | 2.2 | 2.3 | 1.5 | 1.4 | 3.7 | 0.9 | 1.1 | 4.0 | 3.0 | 2.2 | 10 | |
| 0.0 | -30 | -37 | -82 | 24 | 9.8 | 5.1 | -64 | 124 | -4.0 | -12 | -304 | -196 | |
| 61 | 55 | 219 | 0.7 | 0.3 | 20 | 162 | -0.1 | 45 | 433 | -0.1 | 1.1 | 479 | |
| 52 | 8.0 | 171 | -104 | -9.8 | -12 | 114 | -114 | 129 | 381 | -71 | -365 | 74 | |
| -8.7 | -18 | -13 | -26 | -36 | -43 | -57 | -50 | -42 | -52 | -62 | -64 | -219 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.